Emily Maria Ploeg
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 21, 2023
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR.Emily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong
|Jul 29, 2023
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer.Emily Maria Ploeg, Isabel Britsch, Anne Paulien van Wijngaarden
|May 14, 2023
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells.Isabel Britsch, Anne P van Wijngaarden, Xiurong Ke
|Dec 03, 2021
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis.Mark A J M Hendriks, Isabel Britsch, Xiurong Ke
|Dec 10, 2020
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.Mark A J M Hendriks, Emily M Ploeg, Iris Koopmans
|Sep 14, 2019
Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC.Paul B M Essers, Martijn van der Heijden, Caroline V M Verhagen
Pageof 1
Frequent Collaborators
4 joint publications
Mark Alexander Johannes Martinus Hendriks
4 joint publications
Isabel Britsch
4 joint publications
Douwe Freerk Samplonius
4 joint publications
Wijnand Helfrich
3 joint publications
Anne Paulien van Wijngaarden
2 joint publications
Xiurong Ke
2 joint publications
Xiurong Ke
1 joint publications
Michiel W M van den Brekel
1 joint publications
Iris Koopmans
1 joint publications
Hao Zhang
